Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Jubilant Life Sciences’ Bengaluru-based subsidiary Jubilant Biosys and Endo Pharmaceuticals have achieved a late stage discovery milestone, under their multiyear, multi-target, oncology focused partnership entered in 2009.
Subscribe to our email newsletter
The third milestone under the collaboration is expected to enable both the firms to rapidly pursue a development candidate.
As a part of the partnership, Jubilant delivers preclinical development candidates and has an option to participate in clinical development.
Endo owns the development and commercial rights to the successful outcomes.
However, Jubilant derives research funding, development milestones and sales royalties on successful commercialization.